文献速递关节外科

抗血栓治疗与全膝全髋关节置换术后假体周围感染风险的12年回顾分析

Antithrombotic Therapies and Their Associations With Periprosthetic Joint Infection Risk After Total Knee and Hip Arthroplasty: A 12-Year Review.
PubMed 文献 · J Arthroplasty · 2026-04-24

该研究回顾2013至2025年20,376例全膝关节置换(TKA)和16,074例全髋关节置换(THA)术后接受抗血栓治疗(ATT)的患者,分析ATT使用趋势及ATT类型与假体周围感染(PJI)的关联。结果显示阿司匹林单药 prophylasis 占比大幅上升,在THA中阿司匹林单药与较低PJI风险相关,而华法林和低分子肝素与THA后PJI风险升高独立相关;TKA队列中未发现该关联。

要点

  • 2013至2025年阿司匹林单药预防占比大幅上升,TKA从2.0%升至59.4%,THA从3.1%升至82.2%。
  • THA中阿司匹林单药较非阿司匹林方案PJI风险更低(校正OR 0.60,95%CI 0.45-0.81,P=0.001)。
  • THA中华法林(OR 8.01)和低分子肝素(OR 1.89)与PJI风险升高独立相关,TKA中无此关联。

核心结论

  • 阿司匹林已成为术后抗血栓治疗的主导药物,在THA中阿司匹林单药与显著降低的PJI风险相关,而华法林和低分子肝素与THA后PJI风险升高独立相关。
  • 在TKA队列中未发现阿司匹林单药与非阿司匹林方案之间PJI风险的显著关联。

研究设计与样本

  • 回顾性队列研究,纳入2013至2025年接受初次TKA(20,376例)和THA(16,074例)术后抗血栓治疗的患者。
  • PJI发生率(采用2018国际共识会议定义)仅在随访至少90天的患者中评估(TKA 14,663例,THA 11,445例)。
  • 采用多因素logistic回归校正年龄、性别、体重指数、吸烟和Charlson合并症指数,评估ATT类型与PJI的关联。

主要发现

  • 2013至2025年,阿司匹林单药占比在TKA从2.0%升至59.4%,THA从3.1%升至82.2%;低分子肝素、华法林和利伐沙班使用下降,阿哌沙班使用上升。
  • 在随访至少90天的患者中,TKA的PJI发生率为0.8%,THA为1.3%。
  • 阿司匹林单药较非阿司匹林方案与更低的PJI odds相关(校正OR 0.60,95%CI 0.45-0.81,P=0.001)。
  • 在THA中,华法林(OR 8.01,95%CI 3.41-18.88,P<0.001)和低分子肝素(OR 1.89,95%CI 1.35-2.64,P<0.001)与PJI风险升高独立相关。

关键数值与推荐

  • PJI定义采用2018国际共识会议标准。
  • PJI分析仅纳入随访至少90天的患者。
  • 多因素回归校正因素包括年龄、性别、体重指数、吸烟和Charlson合并症指数。

临床怎么用

  • 在THA术后抗血栓治疗选择中,可优先考虑阿司匹林单药以降低PJI风险,而非华法林或低分子肝素等强效抗凝药。
  • TKA术后ATT类型与PJI的关联不显著,选择抗血栓方案时需综合权衡血栓与感染风险。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of postoperative antithrombotic therapy (ATT) on complications such as periprosthetic joint infection (PJI) after total knee and hip arthroplasty (TKA and THA, respectively) remains understudied. We aimed to evaluate temporal trends in ATT use and the association between ATT type and PJI following primary TKA and THA. METHODS: We retrospectively reviewed 20,376 TKA and 16,074 THA patients receiving postoperative ATT between 2013 and 2025. Trends in ATT use were analyzed for all patients, but PJI incidence (2018 International Consensus Meeting definition) was assessed only in patients who had a minimum 90-day follow-up (14,663 TKA and 11,445 THA). Of these, 0.8 and 1.3% developed a PJI, respectively. Multivariate logistic regressions adjusted for age, sex, body mass index, smoking, and the Charlson Comorbidity Index were applied to assess the association between ATT and PJI. RESULTS: From 2013 to 2025, aspirin monotherapy increased to account for the majority of prophylaxis (TKA: 2.0 to 59.4%; THA: 3.1 to 82.2%). In contrast, the use of low-molecular-weight heparin (LMWH) declined (TKA: 87.6 to 0.8%; THA: 86.7 to 2.3%), as did warfarin (TKA: 4.1 to 0.3%; THA: 3.4 to 0.9%) and rivaroxaban (TKA: 6.8 to 4.2%; THA: 8.9 to 2.8%). During the same period, apixaban use increased (TKA: 0 to 10.0%; THA: 0 to 12.7%). Aspirin monotherapy was associated with lower odds of PJI compared to nonaspirin regimens (adjusted odds ratio [OR] 0.60, 95% confidence interval [CI] 0.45 to 0.81, P = 0.001). Conversely, warfarin (OR: 8.01, 95% CI: 3.41 to 18.88, P < 0.001) and LMWH (OR: 1.89, 95% CI: 1.35 to 2.64, P < 0.001) were independently associated with increased PJI risk in THA. CONCLUSIONS: Aspirin has become the dominant postoperative ATT agent. In THA, aspirin is associated with a significantly decreased risk of PJI compared to potent anticoagulants like warfarin and LMWH, while no such association was found in the TKA cohort. Surgeons should prioritize aspirin to minimize postoperative infection risk.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Khury F, Sarfraz A, Padon BW, et al. Antithrombotic Therapies and Their Associations With Periprosthetic Joint Infection Risk After Total Knee and Hip Arthroplasty: A 12-Year Review. J Arthroplasty. 2026. PMID: 42036085. doi:10.1016/j.arth.2026.04.073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。